Literature DB >> 30665965

Metabolic (Bariatric and Nonbariatric) Surgery for Type 2 Diabetes: A Personal Perspective Review.

Henry Buchwald1,2, Jane N Buchwald3.   

Abstract

: Metabolic surgery can cause amelioration, resolution, and possible cure of type 2 diabetes. Bariatric surgery is metabolic surgery. In the future, there will be metabolic surgery operations to treat type 2 diabetes that are not focused on weight loss. These procedures will rely on neurohormonal modulation related to the gut as well as outside the peritoneal cavity. Metabolic procedures are and will always be in flux as surgeons seek the safest and most effective operative modality; there is no enduring gold standard operation. Metabolic bariatric surgery for type 2 diabetes is more than part of the clinical armamentarium, it is an invitation to perform basic research and to achieve fundamental scientific knowledge.
© 2019 by the American Diabetes Association.

Entities:  

Mesh:

Year:  2019        PMID: 30665965     DOI: 10.2337/dc17-2654

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  15 in total

1.  Standardization of Bariatric Metabolic Procedures: World Consensus Meeting Statement.

Authors:  Mohit Bhandari; M A L Fobi; Jane N Buchwald
Journal:  Obes Surg       Date:  2019-07       Impact factor: 4.129

Review 2.  Executive Summary: Collected Papers of the American College of Surgeons Metabolic Surgery Symposium.

Authors:  Henry Buchwald; J N Buchwald; Walter J Pories; David B Hoyt
Journal:  Obes Surg       Date:  2020-05       Impact factor: 4.129

3.  Obesity surgery and eating and weight disorders: a new topical collection of EWD.

Authors:  Gianfranco Silecchia
Journal:  Eat Weight Disord       Date:  2020-05-26       Impact factor: 4.652

4.  Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.

Authors:  Yong Yan; Yanhua Sha; Xianzhang Huang; Wei Yuan; Fan Wu; Jinsong Hong; Shaomei Fang; Bo Huang; Cheng Hu; Bailin Wang; Xueli Zhang
Journal:  Obes Surg       Date:  2019-09       Impact factor: 4.129

Review 5.  Revision of Roux-en-Y Gastric Bypass for Inadequate Weight Loss or Weight Regain.

Authors:  Andreas Alexandrou; Panagiotis Sakarellos; Spyridon Davakis; Michail Vailas; Nikoletta Dimitriou; Alexandros Papalampros; Dimitrios Schizas; Alexandros Charalabopoulos; Evangelos Felekouras
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

6.  Reverse Transposition - a New Surgical Model for the Study the Role of Ileum in Glucose Metabolism.

Authors:  L V Sevastyanov; E M Turgunov; D V Shestakov
Journal:  Bull Exp Biol Med       Date:  2022-03-30       Impact factor: 0.804

7.  Molecular remodeling of adipose tissue is associated with metabolic recovery after weight loss surgery.

Authors:  Annie Bouchard-Mercier; Juan de Toro-Martín; Mélanie Nadeau; Odette Lescelleur; Stéfane Lebel; Denis Richard; Laurent Biertho; André Tchernof; Marie-Claude Vohl
Journal:  J Transl Med       Date:  2022-06-23       Impact factor: 8.440

8.  Once-Weekly Semaglutide Induces an Early Improvement in Body Composition in Patients with Type 2 Diabetes: A 26-Week Prospective Real-Life Study.

Authors:  Sara Volpe; Giuseppe Lisco; Davide Racaniello; Margherita Fanelli; Valentina Colaianni; Alfredo Vozza; Vincenzo Triggiani; Carlo Sabbà; Cosimo Tortorella; Giovanni De Pergola; Giuseppina Piazzolla
Journal:  Nutrients       Date:  2022-06-10       Impact factor: 6.706

9.  Intramuscular injection of sotagliflozin promotes neovascularization in diabetic mice through enhancing skeletal muscle cells paracrine function.

Authors:  Lai-Liu Luo; Jing-Xuan Han; Shou-Rong Wu; Vivi Kasim
Journal:  Acta Pharmacol Sin       Date:  2022-03-15       Impact factor: 7.169

10.  The Effects of Bariatric Surgery on Type 2 Diabetes in Asian Populations: a Meta-analysis of Randomized Controlled Trials.

Authors:  Jin Hwa Kim; Jung-Soo Pyo; Won Jin Cho; Sang Yong Kim
Journal:  Obes Surg       Date:  2020-03       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.